Fighting the Wrong Enemy: Antibacteriophage Immunity in Phage Therapy
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiac369 ↗Kurz gefasst
Editorial in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Jerome M Molleston und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Washington University, St Louis, Missouri, USA. Hauptthemen laut MEDLINE: Bacteriophages, Phage Therapy, Pneumonia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, Washington University, St Louis, Missouri, USA.
Förderung
- NIDDK NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Molleston, J. M., & Holtz, L. R. (2023). Fighting the Wrong Enemy: Antibacteriophage Immunity in Phage Therapy. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiac369
Vancouver
Molleston JM, Holtz LR. Fighting the Wrong Enemy: Antibacteriophage Immunity in Phage Therapy. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiac369
BibTeX
@article{Molleston2023,
author = {Molleston, Jerome M and Holtz, Lori R},
title = {Fighting the Wrong Enemy: Antibacteriophage Immunity in Phage Therapy},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiac369}
}
EUVIMED